logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
ESSA
ESSA Bancorp, Inc.
20.61
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
timesize
Ytd5.69%
1y2.33%
20.20
day range
21.07
15.82
52 week range
22.22
Open20.44Prev Close20.61Low20.20High21.07Mkt Cap209.29M
Vol0.00Avg Vol49.44KEPS1.55P/E13.30Forward P/E9.97
Beta0.43Short Ratio1.75Inst. Own46.44%Dividend0.60Div Yield2.91
Ex Div Date12-16EarningN/A50-d Avg19.26200-d Avg19.571yr Est0.00

ESSA News

ESSA Announces Completion of Arrangement with XenoTherapeutics
prnewswire.com
ESSA Announces Completion of Arrangement with XenoTherapeutics

SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada , Oct. 9, 2025 /PRNewswire/ - ESSA Pharma

ESSA Securityholders Approve Acquisition by XenoTherapeutics
prnewswire.com
ESSA Securityholders Approve Acquisition by XenoTherapeutics

SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada , Oct. 6, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDA

ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
prnewswire.com
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Ame

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , Sept.

K12 Tutoring Strengthens ESSA Validation with New Multi-Grade Results
globenewswire.com
K12 Tutoring Strengthens ESSA Validation with New Multi-Grade Results

RESTON, VA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- K12 Tutoring, part of the Stride, Inc. (NYSE: LRN) po

ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
prnewswire.com
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics

Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction a

CNB Financial Corporation Completes Merger with ESSA Bancorp, Inc.
globenewswire.com
CNB Financial Corporation Completes Merger with ESSA Bancorp, Inc.

CLEARFIELD, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB” or the “Company”

ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders
prnewswire.com
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for App

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , July 23, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESS

ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
prnewswire.com
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC and BOSTON and EMERYVILLE, Calif.

CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger
accessnewswire.com
CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger

CLEARFIELD, PA and STROUDSBURG, PA / ACCESS Newswire / June 30, 2025 / CNB Financial Corporation ("C

CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger
globenewswire.com
CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger

CLEARFIELD, Pa. and STROUDSBURG, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“

ESSA Bancorp, Inc. Declares Quarterly Dividend
accessnewswire.com
ESSA Bancorp, Inc. Declares Quarterly Dividend

STROUDSBURG, PA / ACCESS Newswire / May 21, 2025 / ESSA Bancorp, Inc. (NASDAQ Global MarketSM:ESSA),

ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025
prnewswire.com
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025

Company continues to explore and review strategic options focused on maximizing shareholder value SO

K12 Tutoring Earns ESSA Level II Validation, Confirming Impact on Student Achievement
globenewswire.com
K12 Tutoring Earns ESSA Level II Validation, Confirming Impact on Student Achievement

An independently validated study highlighted K12 Tutoring's success in personalized, academic suppor

ESSA Bancorp, Inc. Announces Fiscal Second Quarter and Fiscal First Half 2025 Financial Results
accessnewswire.com
ESSA Bancorp, Inc. Announces Fiscal Second Quarter and Fiscal First Half 2025 Financial Results

STROUDSBURG, PA / ACCESS Newswire / April 23, 2025 / ESSA Bancorp, Inc. (the "Company") (NASDAQ:ESSA

CNB Financial Corporation Announces that ISS Recommends Shareholders Support the Proposal to Issue Common Stock in connection with the Merger with ESSA Bancorp, Inc., the Proposal to Approve the 2025 Omnibus Incentive Plan and the Say-on-Pay Proposal
globenewswire.com
CNB Financial Corporation Announces that ISS Recommends Shareholders Support the Proposal to Issue C

CLEARFIELD, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB”) (NASDAQ: CCNE)

Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX
accessnewswire.com
Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Yo

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your ESSA Pharma Inc. (N

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
prnewswire.com
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Cl

NEW YORK , March 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ESSA Pharma In

ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX
accessnewswire.com
ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Befo

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your ESSA Pharma Inc. (N

ESSA Pharma Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EPIX
accessnewswire.com
ESSA Pharma Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your ESSA Pharma Inc. (N

ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2025 Deadline to file Lead Plaintiff Motion
globenewswire.com
ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 20

Investors can contact the law firm at no cost to learn more about recovering their losses